PARTIAL CHARACTERIZATION OF NOCARDIA-FARCINICA BETA-LACTAMASES

被引:18
作者
STEINGRUBE, VA
WALLACE, RJ
BROWN, BA
ZHANG, YS
STEELE, LC
YOUNG, G
NASH, DR
机构
[1] Department of Microbiology, University of Texas Health Center, Tyler, TX 75710
关键词
D O I
10.1128/AAC.37.9.1850
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The beta-lactamases obtained from culture supernatants and cell extracts of 26 clinical strains and 5 reference strains of Nocardia farcinica were partially characterized. The enzymes exhibited two patterns on isoelectric focusing (IEF). Beta-lactamases from the majority of the 31 strains (87%) including the 5 reference strains exhibited two major bands with pIs of 4.56 and 4.49. The remaining strains had two similar major bands but with slightly higher pIs. Culture supernatants and cell extracts exhibited identical patterns. The two sets of enzymes were functionally indistinguishable by substrate and inhibitor profiles and lack of inducibility. By disk testing, ampicillin, amoxicillin, ticarcillin, amoxicillin-clavulanic acid, and imipenem were highly synergistic with cefotaxime. The enzymes were primarily penicillinases and hydrolyzed cephalosporins at rates of less-than-or-equal-to 12% of those for penicillins. N. farcinica beta-lactamases were susceptible to inhibition by clavulanic acid and BRL 42715, exhibiting 50% inhibitory concentrations of 0.025 to 0.045 mug/ml (0.12 to 0.22 muM) and 0.05 to 0.1 mug/ml (0.31 to 0.63 muM), respectively, less susceptible to tazobactam, and least susceptible to sulbactam, cloxacillin, and imipenem. The beta-lactamases of N. farcinica are believed to mediate penicillin resistance and may play a secondary role in extended-spectrum cephalosporin resistance. The close similarity among N. farcinica beta-lactamases and their distinct differences from beta-lactamases of other Nocardia species support the taxonomic identity of this species.
引用
收藏
页码:1850 / 1855
页数:6
相关论文
共 24 条
[1]  
BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
[3]   RESISTANCE CAUSED BY DECREASED PENETRATION OF BETA-LACTAM ANTIBIOTICS INTO ENTEROBACTER-CLOACAE [J].
BUSH, K ;
TANAKA, SK ;
BONNER, DP ;
SYKES, RB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (04) :555-560
[4]   INVITRO EVALUATION OF BRL 42715, A NOVEL BETA-LACTAMASE INHIBITOR [J].
COLEMAN, K ;
GRIFFIN, DRJ ;
PAGE, JWJ ;
UPSHON, PA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (09) :1580-1587
[5]   MORE EXTENDED-SPECTRUM BETA-LACTAMASES [J].
JACOBY, GA ;
MEDEIROS, AA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (09) :1697-1704
[6]  
KITZIS MD, 1985, J ANTIMICROB CHEMOTH, V15, P23, DOI 10.1093/jac/15.1.23
[8]   CONTRIBUTION OF BETA-LACTAMASE HYDROLYSIS AND OUTER-MEMBRANE PERMEABILITY TO CEFTRIAXONE RESISTANCE IN ENTEROBACTER-CLOACAE [J].
MARCHOU, B ;
BELLIDO, F ;
CHARNAS, R ;
LUCAIN, C ;
PECHERE, JC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (10) :1589-1595
[9]   DETECTION OF BETA-LACTAMASE PRODUCTION BY GRAM-NEGATIVE BACTERIA [J].
MASUDA, G ;
TOMIOKA, S ;
HASEGAWA, M .
JOURNAL OF ANTIBIOTICS, 1976, 29 (06) :662-664
[10]   INDUCTION OF BETA-LACTAMASE BY VARIOUS BETA-LACTAM ANTIBIOTICS IN ENTEROBACTER-CLOACAE [J].
MINAMI, S ;
YOTSUJI, A ;
INOUE, M ;
MITSUHASHI, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (03) :382-385